Literature DB >> 8656268

Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel.

A A Miller, R C Lilenbaum, T J Lynch, G L Rosner, M J Ratain, M R Green, R L Schilsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8656268     DOI： 10.1200/JCO.1996.14.6.1964

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.

Authors:  J Marc Pipas; Louise P Meyer; C Harker Rhodes; Laurence D Cromwell; Carol E McDonnell; Linda S Kingman; James R Rigas; Camilo E Fadul
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

2.  A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study.

Authors:  Deborah K Armstrong; Michael A Bookman; William McGuire; Robert E Bristow; Jeanne M Schilder
Journal:  Gynecol Oncol       Date:  2007-03-21       Impact factor: 5.482

Review 3.  Topoisomerase I targeting agents in small-cell lung cancer.

Authors:  Y Ohe; N Saijo
Journal:  Curr Oncol Rep       Date:  2001-03       Impact factor: 5.945
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.